Neeraj Thakur | Pharmacology | Innovative Research Award

Innovative Research Award

Neeraj Thakur
Affiliation University of Oklahoma Health Campus
Country United States
Scopus ID 56645996700
Documents 37
Citations 1,149
h-index 20
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0003-1758-0737

Neeraj Thakur
University of Oklahoma Health Campus, United States

The Innovative Research Award recognizes sustained scholarly excellence, impactful scientific contributions, and innovation in biomedical and pharmaceutical sciences. Neeraj Thakur has established an active research profile focused on advanced drug delivery systems, nanomedicine, pharmaceutical formulations, biomaterials, and translational therapeutic technologies. His published work demonstrates interdisciplinary collaboration across pharmaceutical science, toxicology, and biomedical engineering while contributing to improved therapeutic delivery strategies for dermatological and ocular applications.[1]

Abstract

Neeraj Thakur’s research integrates pharmaceutical sciences, nanotechnology, biomaterials, and targeted therapeutic delivery to address challenges associated with drug stability, controlled release, tissue targeting, and improved clinical efficacy. His work encompasses hybrid micellar systems, ocular nanoformulations, RNA interference technologies, and advanced pharmaceutical carriers designed to improve patient outcomes through innovative formulation strategies.[2]

Keywords

Drug Delivery Systems, Nanomedicine, Hybrid Micelles, RNA Interference, Corneal Therapeutics, Pharmaceutical Sciences, Targeted Drug Delivery

Introduction

Modern pharmaceutical research increasingly focuses on precision drug delivery, sustained therapeutic release, and biomaterial-enabled treatment strategies. Neeraj Thakur’s research aligns with these objectives through the development of multifunctional nanocarriers and advanced pharmaceutical formulations capable of enhancing therapeutic performance while minimizing adverse effects. His publications demonstrate an interdisciplinary approach combining pharmaceutical sciences with materials engineering and translational medicine.[3]

Research Profile

  • Scopus Author ID: 56645996700
  • 37 indexed scholarly publications.
  • 1,149 citations reflecting broad scientific visibility.
  • h-index of 20 demonstrating consistent research influence.
  • Research spans pharmacology, toxicology, pharmaceutical sciences, nanomedicine and biomaterials.

Research Contributions

The research contributions of Neeraj Thakur include the design of crosslinked hybrid micellar systems for cutaneous drug delivery, sustained nanoformulations for corneal wound healing, and RNA interference applications in viral diagnostics and therapeutics. These investigations emphasize formulation optimization, targeted delivery, therapeutic efficiency, and translational biomedical applications while supporting the broader advancement of pharmaceutical technology.[4]

Publications

  • Crosslinked hybrid micellar platform for targeted cutaneous drug delivery
    Colloids and Surfaces B: Biointerfaces (2026). DOI: 10.1016/j.colsurfb.2026.115998
  • Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery
    Preprint (2026). DOI: 10.2139/ssrn.6250431
  • A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation
    Nanomedicine (2025). DOI: 10.1080/17435889.2025.2550236
  • RNAi in viral control and diagnostics
    Book Chapter (2025). DOI: 10.1088/978-0-7503-4987-1ch12

Research Impact

The documented citation profile, publication record, and interdisciplinary research portfolio indicate sustained academic influence within pharmaceutical sciences. Contributions toward targeted drug delivery technologies and nanomedicine support ongoing developments in precision therapeutics, controlled release formulations, and biomedical innovation. The citation metrics further demonstrate recognition by the international research community.[1]

Award Suitability

Based on the available scholarly metrics, publication output, interdisciplinary research contributions, and demonstrated impact within pharmaceutical sciences, Neeraj Thakur represents a suitable candidate for recognition through the Innovative Research Award. His research portfolio reflects innovation in drug delivery technologies, sustained scientific productivity, and contributions supporting future translational healthcare solutions.[2]

Conclusion

Neeraj Thakur has established a notable research profile characterized by innovation in pharmaceutical formulation science, targeted therapeutic delivery, nanotechnology, and biomaterial-based treatment strategies. Supported by strong bibliometric indicators and peer-reviewed scholarly publications, his work contributes to the continued advancement of pharmaceutical sciences and biomedical research while reflecting the qualities recognized by the Innovative Research Award.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Neeraj Thakur, Author ID 56645996700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56645996700
  2. Thakur, N. (2026). Crosslinked hybrid micellar platform for targeted cutaneous drug delivery. Colloids and Surfaces B: Biointerfaces.
    https://doi.org/10.1016/j.colsurfb.2026.115998
  3. Thakur, N. (2026). Crosslinked Hybrid Micellar Platform for Targeted Cutaneous Drug Delivery. SSRN Preprint. https://doi.org/10.2139/ssrn.6250431
  4. Thakur, N. (2025). A multimodal approach to smart and sustained drug delivery for corneal wound management: the GelPol nanoformulation. Nanomedicine. https://doi.org/10.1080/17435889.2025.2550236
  5. Thakur, N. (2025). RNAi in viral control and diagnostics. Viral Diseases: History and New Developments in Diagnostics and Therapeutics.
    https://doi.org/10.1088/978-0-7503-4987-1ch12

Mohammad Asif | Pharmaceutical chemistry | Best Researcher Award

Dr. Mohammad Asif | Pharmaceutical chemistry | Best Researcher Award

Professor at Era College of Pharmacy Era University Lucknow, India

Dr. Mohammad Asif is a distinguished researcher and academician specializing in pharmaceutical sciences. He is currently serving as a Professor of Pharmacy at Era Medical College of Pharmacy, Era University, Lucknow, India. With decades of experience in medicinal chemistry, Dr. Asif has made substantial contributions to the synthesis and evaluation of bioactive compounds, focusing on drug development and computational pharmacology.

Profile

ORCID

Education📘

Dr. Asif holds advanced degrees in Pharmacy, with a strong foundation in medicinal chemistry and pharmacology. His academic journey has been enriched by continuous learning and research, enabling him to contribute significantly to innovative drug design.

Experience👨‍🏫

Over the years, Dr. Asif has held several academic and research positions, culminating in his current role as a Professor. His experience spans teaching, mentoring students, and conducting cutting-edge research in medicinal chemistry and pharmacology.

Research Interests🔬

Dr. Asif’s research interests include:

  • Green synthesis and computational studies for drug discovery.
  • Developing bioactive heterocyclic compounds for antimicrobial and antiviral properties.
  • Exploring pharmacological potentials of molecules like pyrazoles, pyrimidines, and oxazines.

Awards and Recognition🏆

Dr. Asif has received numerous accolades for his contributions to pharmaceutical sciences, including recognition for his innovative research on bioactive compounds and his impactful publications in high-impact journals.

Publications📚

Dr. Asif has authored 60 research articles, many of which are widely cited in the scientific community. Below is a selection of his notable works:

Computational Studies and Antimicrobial Activity of 1-(benzo[d]oxazol-2-yl)-3,5-diphenylformazan Derivatives

  • Year: 2024-12
  • Journal: Current Computer-Aided Drug Design
  • DOI: 10.2174/1573409919666230703103135

Diverse Pharmacological Potential of Different Substituted Pyrazole Derivatives

  • Year: 2024-11
  • Journal: Current Organic Synthesis
  • DOI: 10.2174/0115701794260444230925095804

Green Synthetic Methods of Oxazine and Thiazine Scaffolds as Promising Medicinal Compounds: A Mini-review

  • Year: 2024-11
  • Journal: Current Organic Synthesis
  • DOI: 10.2174/1570179420666230811092847

Synthesis, In-Silico Biochemical Properties, and In-Vitro Antimicrobial Activity of Some Farmazans-Sulfonamide Derivatives

  • Year: 2024-11-20
  • Journal: Chemistry & Biodiversity
  • DOI: 10.1002/cbdv.202402488

Towards Antiviral Potential of Biomolecules Derived from Adhatoda vesical as Competent Natural Molecules to Treat COVID-19 Virus Variant

  • Year: 2024-05
  • Journal: Letters in Organic Chemistry
  • DOI: 10.2174/0115701786263427231123103651

An Overview of Various Rifampicin Analogs Against Mycobacterium tuberculosis and Their Drug Interactions

  • Year: 2024-03
  • Journal: Medicinal Chemistry
  • DOI: 10.2174/0115734064260853230926080134

Diverse Pharmacological Potential of Pyridazine Analogs Against Various Diseases

  • Year: 2024-03
  • Journal: Medicinal Chemistry
  • DOI: 10.2174/1573406419666230913102835

Neuropharmacological Potential of Different Piperazine Analogs: A Recent Prospective

  • Year: 2024-01-16
  • Journal: Mini-Reviews in Organic Chemistry
  • DOI: 10.2174/0118756298277743231213065544

An Overview of Diverse Biological Activities of Cinnoline Scaffold

  • Year: 2024-01-04
  • Journal: Mini-Reviews in Organic Chemistry
  • DOI: 10.2174/0118756298265037231119063008

Diverse Pharmacological Potential of Various Substituted Pyrimidine Derivatives

  • Year: 2023-11
  • Journal: Current Organic Chemistry
  • DOI: 10.2174/0113852728266665231101112129

For the complete list of publications, visit Dr. Mohammad Asif’s ORCID.

Conclusion💡

Dr. Mohammad Asif’s illustrious career reflects his dedication to advancing pharmaceutical sciences. His pioneering research on bioactive compounds and green synthesis methods continues to inspire innovation in drug discovery. A passionate educator and prolific author, Dr. Asif remains committed to fostering scientific progress for better healthcare solutions.